Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jingyin Granules
- Development stage
- Unknown
- Lead developer
- Shuguang Hospital
- Administration
- Oral
01
Overview
Jingyin Granules is a marketed traditional Chinese medicine (TCM) herbal formulation developed as an in-hospital preparation at Shanghai Shuguang Hospital, affiliated with Shanghai University of Traditional Chinese Medicine. It is a complex multi-herb mixture derived from the classical TCM formula Yinqiao Powder, composed of nine herbs including Herba Schizonpetae (Jing Jie), Flos Lonicerae (Jin Yin Hua), Herba Taraxaci (Pu Gong Ying), Indigowoad Leaf (Da Qing Ye), and Folium Ilicis Purpureae (Si Ji Qing). Clinically used for over 40 years, it is indicated for respiratory diseases such as acute bronchitis, acute pneumonia, H1N1 influenza A virus infection, and COVID-19. The formulation exhibits antiviral and anti-inflammatory properties and has been shown to inhibit various drug-metabolizing enzymes, including carboxylesterases and cytochrome P450 isoforms.
- Brand names
- Jingyin Granules
- Other names
- 荆银颗粒Jingyin granule
02
Targets
CYP2A6 (Cytochrome P450 2A6)CYP2D6 (Cytochrome P450 2D6)CYP2C9 (Cytochrome P450 family 2 subfamily C member 9)CES1 (Liver carboxylesterase 1)CYP1A (Cytochrome P450 family 1 subfamily A)CYP2C8 (Cytochrome P450 2C8)CYP2E1CES2 (Carboxylesterase 2)
Beyond the preview
Go deeper on Jingyin Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jingyin Granules.